Here are relevant reports on : adult-entertainment-market
-
Enteral Feeding Devices Market By Type (Enteral Feeding Tubes, Nasogastric Tubes, Enteral Feeding Syringes, Nasal Feeding Tubes), Insertion Method, Age Group (Adult, Pediatric), Application (Oncology, Hypermetabolism), End User - Global Forecast to 2032
The global enteral feeding devices market, valued at US$3.12 billion in 2024, stood at US$3.27 billion in 2025 and is projected to advance at a resilient CAGR of 5.5% from 2024 to 2032, culminating in a forecasted valuation of US$4.76 billion by the end of the period. Market growth is driven by the increasing geriatric population, technological advancements, regulatory support, greater awareness of nutritional needs, and expansion in emerging economies.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Conjugate Vaccines Market by Disease (Pneumococcal, DTP, Meningococcal Disease), Type (Monovalent, Multivalent), End User (Adult, Pediatric) - Forecast to 2030
The global conjugate vaccines market, valued at US$15.86 billion in 2024, stood at US$15.25 billion in 2025 and is projected to advance at a resilient CAGR of 7.4% from 2025 to 2030, culminating in a forecasted valuation of US$21.77 billion by the end of the period. The conjugate vaccines market is growing rapidly, driven by the rising prevalence of bacterial infections like pneumococcal, meningococcal, and Hemophilus influenzae type b (Hib), rising government immunization programs and policies, innovations in vaccine technology such as multivalent formulations, increased regulatory approvals for new products, and growing investments in research, development, and international collaborations.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Gummy Vitamins Market by Product Type (Multivitamins, Single Vitamins), Source (Animal, Plant), Packaging Type (Bottles & Jars, Pouches), Distribution Channel (Store-Based, Online), End User (Adult, Children), and Region - Global Forecast to 2025
According to MarketsandMarkets, the global gummy vitamins market is projected to reach USD 10.6 billion by 2025, recording a CAGR of 12.5% during the forecasting period. This report includes a study on the marketing and development strategies, along with the product portfolios of leading companies. It consists of profiles of leading companies, such as Church & Dwight Co. Inc. (US), Life Science Nutritionals (Canada), Bettera Brands LLC (US), Softigel (US), Nature's Way Products, LLC (US), Zanon Vitamec Inc. (US), Olly Public Benefit Corporation (US), Herbaland Naturals Inc. (Canada), Hero Nutritionals, LLC (US), SmartyPants Inc. (US), The Nature's Bounty Co. (US), IM Healthcare (India), Nutra Solutions (US), Makers Nutrition, LLC (US), Vitakem Nutraceutical Inc. (US), Bayer Group (Germany), The Clorox Company (US), Ernest Jackson (UK), Boscogen, Inc (US), and Santa Cruz Nutritionals Inc. (US).
- Published: October 2020
- Price: $ 4950
- TOC Available:
-
Latin America Enteral Feeding Devices Market by Type (Enteral Feeding, Nasogastric Tubes, Enteral Feeding Syringes, Nasal Feeding, Nasoduodenal), Insertion Method, Age Group (Adult, Pediatric), Application (Oncology, Hypermetabolism), End User - Forecast to 2032
The Latin America Enteral Feeding Devices market, valued at USD 0.24 billion in 2025, stood at USD 0.25 billion in 2026 and is projected to advance at a resilient CAGR of 5.2% from 2026 to 2032, culminating in a forecasted valuation of USD 0.34 billion by the end of the period. The increase in the market is due to the growing cases of chronic and acute diseases that are difficult to manage without long-term nutritional support.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
US Telehealth & Telemedicine Market by Function (Clinical Care, Teleconsult, RPM, Patient Engagement, Analytics), Application (TeleICU, Teleradiology, Telecardiology, Diabetes), Age (Adult, Pediatric), End User (Hospital, Payer, ASC) - Forecast to 2030
The US Telehealth & Telemedicine Market, valued at US$46.10 billion in 2024, stood at US$51.40 billion in 2025 and is projected to advance at a resilient CAGR of 10.2% from 2025 to 2030, culminating in a forecasted valuation of US$83.63 billion by the end of the period. In the US, permanent CMS reimbursement expansions and state-level payment parity laws are driving telehealth growth by securing fair, ongoing reimbursement comparable to in-person care.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Cerebrospinal Fluid Management Market by Product (Shunts (Ventriculoperitoneal, Ventriculoatrial, Adjustable Valve), External Drainage Systems (EVD, Lumbar Drainage)), End User (Pediatric, Adult, Geriatric) - Global Forecast to 2022
The global cerebrospinal fluid management market is projected to reach USD 1.56 Billion by 2022 from an estimated USD 1.26 Billion in 2017, at a CAGR of 4.4% during the forecast period. The growth of this market is majorly driven by factors such as the growing geriatric population and the high prevalence of hydrocephalus and the subsequent increase in the number of shunting procedures. The key players in the global cerebrospinal fluid (CSF) management market are Medtronic (Ireland), Integra (US), B. Braun (Germany), DePuy Synthes (US), Spiegelberg GmbH & Co. KG (Germany), SOPHYSA (France), Natus Medical Incorporated (US), Dispomedica GmbH (Germany), Delta Surgical Limited (UK), Argi Grup (Turkey), Moller Medical GmbH (Germany), G. SURGIWEAR LTD. (India), and Wellong Instruments Co., Ltd. (Taiwan).
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Resuscitation Devices Market by Product (Defibrillator, Endotracheal & Tracheostomy Tube, Masks, Airways, Laryngoscopes, Resuscitators, Ventilators), Patient Type (Neonatal, Adult), End User (Hospital, Ambulance, ICU), Volume & Region - Global Forecasts to 2025
The global resuscitation devices market in terms of revenue was estimated to be worth $6.9 billion in 2020 and is poised to reach $8.7 billion by 2025, growing at a CAGR of 4.7% from 2020 to 2025. Prominent players in this market includes Koninklijke Philips N.V. (Netherlands), Medtronic plc (Ireland), ZOLL Medical Corporation (US), ResMed Inc. (US), Physio-Control (acquired by Stryker Corporation) (US), Drägerwerk AG & Co. KGaA (Germany), Smiths Medical (US), Ambu (Denmark), Cardinal Health (US), Mindray Medical (China), Nihon Kohden (Japan), Teleflex (US), Salter Labs (US), GE Healthcare (US), Roper Technologies (US), Vyaire Medical (US), Intersurgical (UK), 3M (US), Flexicare (UK), and KARL STORZ (Germany).
- Published: March 2020
- Price: $ 4950
- TOC Available:
-
CAR T-Cell Therapy Market by Product (Abecma, Breyanzi, Carvykti, Yescarta, Tecartus, Kymriah), Target (CD19, BCMA), Indication (Multiple Myeloma, Leukemia, Lymphoma), Demographic (Adult, Pediatric), Region, Competitive Landscape - Global Forecast to 2031
The global CAR T-cell therapy market, valued at USD 5.98 billion in 2025, stood at USD 6.78 billion in 2026 and is projected to advance at a resilient CAGR of 14.9% from 2026 to 2031, culminating in a forecasted valuation of USD 13.56 billion by the end of the period. The global CAR T-cell therapy market is growing due to rapid technological advances alongside rising investments from large pharma and well-funded biotech's.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Ventilators Market by Mobility (Intensive Care Ventilators, Transportable Ventilators), Type (Adult & Pediatric Ventilators), Interface (Hybrid Ventilation), Mode (Combined Mode Ventilation), Care Setting (Hospitals & Clinics) - Global Forecast to 2029
The global ventilators market, valued at US$3.86B in 2023, is forecasted to grow at a 4.7% CAGR, reaching US$3.71B by 2024 and US$4.66B by 2029. The demand for invasive and non-invasive ventilator systems has increased due to the rapidly growing geriatric population and the increasing rates of respiratory diseases such as pneumonia, ARDS, and COPD.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Bunion Surgery Market by Product (Correction Systems, Implants & Accessories), Patient Type (Adult, Pediatric), Type (Minimally Invasive Surgery, Traditional Surgery), End User (Hospitals, ASCs, Orthopedic Clinics), Region - Global Forecast to 2029
The global bunion surgery market, valued at US$437.8 million in 2023, stood at US$458.4 million in 2024 and is projected to advance at a resilient CAGR of 5.7% from 2024 to 2029, culminating in a forecasted valuation of US$606.1 million by the end of the period. The main factor driving this market is the rising prevalence of bunions, which has led to an increased demand for surgical treatments.
- Published: January 2025
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
